$NKLA
Nikola Corp Stock $nkla

$nkla Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-Q Financial Statement

#000173128921000124 Filed on November 04, 2021

Income Statement

Concept	2021 Q4	2021 Q3	2020 Q4
Revenue	$0.00	$0.00	$0.00
YoY Change			-100.0%
Cost Of Revenue	$0.00	$0.00	$0.00
YoY Change			-100.0%
Gross Profit	$0.00	$0.00	$0.00
YoY Change			-100.0%
Gross Profit Margin
Selling, General & Admin	$71.55M	$192.9M	$64.90M
YoY Change	10.24%	193.29%	1159.27%
% of Gross Profit
Research & Development	$91.17M	$78.90M	$67.52M
YoY Change	35.02%	53.21%	196.39%
% of Gross Profit
Depreciation & Amortization	$2.272M	$2.200M	$1.590M
YoY Change	42.89%	46.67%
% of Gross Profit
Operating Expenses	$162.7M	$271.8M	$146.8M
YoY Change	10.81%	131.78%	425.65%
Operating Profit	-$162.7M	-$271.8M	-$146.8M
YoY Change	10.81%	131.78%	425.74%
Interest Expense	-$262.0K	-$118.0K	-$53.00K
YoY Change	394.34%	-169.01%	-114.17%
% of Operating Profit
Other Income/Expense, Net	$4.072M	$1.057M	-$597.0K
YoY Change	-782.08%	-410.88%	-146.71%
Pretax Income	-$158.9M	-$266.4M	-$147.5M
YoY Change	7.74%	126.8%	461.26%
Income Tax	$0.00	$1.000K	-$1.030M
% Of Pretax Income
Net Earnings	-$159.4M	-$267.6M	-$147.1M
YoY Change	8.38%	235.7%	459.75%
Net Earnings / Revenue
Basic Earnings Per Share		-$0.67
Diluted Earnings Per Share	-$391.2K	-$0.68	-$368.5K
COMMON SHARES
Basic Shares Outstanding	404.4M shares	400.2M shares	384.1M shares
Diluted Shares Outstanding		400.2M shares

Balance Sheet

Concept	2021 Q4	2021 Q3	2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$497.2M	$587.0M	$840.9M
YoY Change	-40.87%	-35.32%	105012.5%
Cash & Equivalents	$497.2M	$587.0M	$840.9M
Short-Term Investments
Other Short-Term Assets	$15.89M	$19.37M	$51.60M
YoY Change	-69.2%	-71.13%
Inventory	$11.60M	$3.644M	$0.00
Prepaid Expenses	$5.116M
Receivables	$0.00		$0.00
Other Receivables			$0.00
Total Short-Term Assets	$524.7M	$610.0M	$896.9M
YoY Change	-41.5%	-38.13%	886.91%
LONG-TERM ASSETS
Property, Plant & Equipment	$244.4M	$200.7M	$71.40M
YoY Change	242.26%	227.26%	33.76%
Goodwill	$5.238M	$5.238M	$5.238M
YoY Change	0.0%	0.0%	0.0%
Intangibles	$97.18M	$97.18M	$50.05M
YoY Change	94.17%	55.57%	-19.94%
Long-Term Investments	$61.78M	$62.37M	$8.420M
YoY Change	633.71%
Other Assets	$3.896M	$0.00	$0.00
YoY Change		-100.0%	-100.0%
Total Long-Term Assets	$465.1M	$390.5M	$156.8M
YoY Change	196.62%	159.76%	13.17%
TOTAL ASSETS
Total Short-Term Assets	$524.7M	$610.0M	$896.9M
Total Long-Term Assets	$465.1M	$390.5M	$156.8M
Total Assets	$989.8M	$1.001B	$1.054B
YoY Change	-6.06%	-11.94%	359.27%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$86.98M	$57.25M	$29.40M
YoY Change	195.86%	455.83%	29300.0%
Accrued Expenses	$95.75M	$170.9M	$17.70M
YoY Change	440.96%	646.22%	8750.0%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$140.0K	$0.00	$4.100M
YoY Change	-96.59%	-100.0%
Total Short-Term Liabilities	$180.6M	$253.1M	$52.27M
YoY Change	245.51%	476.94%	216.08%
LONG-TERM LIABILITIES
Long-Term Debt	$25.05M	$428.0K	$0.00
YoY Change			-100.0%
Other Long-Term Liabilities	$84.03M	$34.73M	$0.00
YoY Change		200.01%	-100.0%
Total Long-Term Liabilities	$84.03M	$34.73M	$0.00
YoY Change		200.01%	-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$180.6M	$253.1M	$52.27M
Total Long-Term Liabilities	$84.03M	$34.73M	$0.00
Total Liabilities	$296.2M	$292.7M	$73.57M
YoY Change	302.66%	417.84%	116.89%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.251B	-$1.091B	-$560.2M
YoY Change	123.25%	156.3%	197.21%
Common Stock	$41.00K	$40.00K	$39.00K
YoY Change	5.13%	2.56%	44.44%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$693.6M	$707.8M	$980.1M
YoY Change
Total Liabilities & Shareholders Equity	$989.8M	$1.001B	$1.054B
YoY Change	-6.06%	-11.94%	359.27%

Cashflow Statement

Concept	2021 Q4	2021 Q3	2020 Q4
OPERATING ACTIVITIES
Net Income	-$159.4M	-$267.6M	-$147.1M
YoY Change	8.38%	235.7%	459.75%
Depreciation, Depletion And Amortization	$2.272M	$2.200M	$1.590M
YoY Change	42.89%	46.67%
Cash From Operating Activities	-$111.8M	-$69.40M	-$65.93M
YoY Change	69.55%	77.75%	19878.79%
INVESTING ACTIVITIES
Capital Expenditures	-$65.59M	-$48.89M	-$7.140M
YoY Change	818.61%	450.6%
Acquisitions
YoY Change
Other Investing Activities	-$3.412M	$0.00	-$8.800M
YoY Change	-61.23%	-100.0%	-4290.48%
Cash From Investing Activities	-$69.00M	-$48.89M	-$15.94M
YoY Change	332.88%	449.36%	-7690.48%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$1.500M		$1.500M
YoY Change	0.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	116.0M	72.58M	8.680M
YoY Change	1236.88%	-72.42%
NET CHANGE
Cash From Operating Activities	-111.8M	-69.40M	-65.93M
Cash From Investing Activities	-69.00M	-48.89M	-15.94M
Cash From Financing Activities	116.0M	72.58M	8.680M
Net Change In Cash	-64.75M	-45.71M	-73.19M
YoY Change	-11.54%	-121.24%	60891.67%
FREE CASH FLOW
Cash From Operating Activities	-$111.8M	-$69.40M	-$65.93M
Capital Expenditures	-$65.59M	-$48.89M	-$7.140M
Free Cash Flow	-$46.20M	-$20.50M	-$58.79M
YoY Change	-21.42%	-32.02%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Entity Central Index Key EntityCentralIndexKey	0001731289
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2019	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate201602Member
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2021-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-38495
	dei	Entity Registrant Name EntityRegistrantName	Nikola Corporation
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	82-4151153
	dei	Entity Address Address Line1 EntityAddressAddressLine1	4141 E Broadway Road
	dei	Entity Address City Or Town EntityAddressCityOrTown	Phoenix
	dei	Entity Address State Or Province EntityAddressStateOrProvince	AZ
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	85040
	dei	City Area Code CityAreaCode	480
	dei	Local Phone Number LocalPhoneNumber	666-1038
	dei	Security12b Title Security12bTitle	Common stock, $0.0001 par value per share
	dei	Trading Symbol TradingSymbol	NKLA
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2021Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	404377685	shares
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	586986000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	840913000	USD
CY2021Q3	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	0	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	4365000	USD
CY2021Q3	us-gaap	Inventory Net InventoryNet	3644000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	0	USD
CY2021Q3	nkla	Prepaid In Kind Services Current PrepaidInKindServicesCurrent	6041000	USD
CY2020Q4	nkla	Prepaid In Kind Services Current PrepaidInKindServicesCurrent	46271000	USD
CY2021Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	13329000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5368000	USD
CY2021Q3	us-gaap	Assets Current AssetsCurrent	610000000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	896917000	USD
CY2021Q3	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	0	USD
CY2020Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	17687000	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	4000000	USD
CY2021Q3	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	25078000	USD
CY2021Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	200655000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	71401000	USD
CY2021Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	97181000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	50050000	USD
CY2021Q3	us-gaap	Equity Method Investments EquityMethodInvestments	62370000	USD
CY2020Q4	us-gaap	Equity Method Investments EquityMethodInvestments	8420000	USD
CY2021Q3	us-gaap	Goodwill Goodwill	5238000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	5238000	USD
CY2021Q3	us-gaap	Assets Assets	1000522000	USD
CY2020Q4	us-gaap	Assets Assets	1053713000	USD
CY2021Q3	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	57251000	USD
CY2020Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	29364000	USD
CY2021Q3	nkla	Accrued Liabilities And Other Liabilities Current AccruedLiabilitiesAndOtherLiabilitiesCurrent	170884000	USD
CY2020Q4	nkla	Accrued Liabilities And Other Liabilities Current AccruedLiabilitiesAndOtherLiabilitiesCurrent	17739000	USD
CY2021Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	24963000	USD
CY2020Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	1070000	USD
CY2021Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	USD
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	4100000	USD
CY2021Q3	us-gaap	Liabilities Current LiabilitiesCurrent	253098000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	52273000	USD
CY2021Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	428000	USD
CY2020Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	13956000	USD
CY2021Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	4428000	USD
CY2020Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	7335000	USD
CY2021Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	34732000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	0	USD
CY2021Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	10000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	8000	USD
CY2021Q3	us-gaap	Liabilities Liabilities	292696000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	73572000	USD
CY2021Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	150000000	shares
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	150000000	shares
CY2021Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000	shares
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000	shares
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	404306242	shares
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	404306242	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	391041347	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	391041347	shares
CY2021Q3	us-gaap	Common Stock Value CommonStockValue	40000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	39000	USD
CY2021Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1799101000	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1540037000	USD
CY2021Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-119000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	239000	USD
CY2021Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1091196000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-560174000	USD
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	707826000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	980141000	USD
CY2021Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1000522000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1053713000	USD
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	0	USD
CY2020Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	0	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	0	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	94000	USD
CY2021Q3	us-gaap	Cost Of Revenue CostOfRevenue	0	USD
CY2020Q3	us-gaap	Cost Of Revenue CostOfRevenue	0	USD
	us-gaap	Cost Of Revenue CostOfRevenue	0	USD
	us-gaap	Cost Of Revenue CostOfRevenue	73000	USD
CY2021Q3	us-gaap	Gross Profit GrossProfit	0	USD
CY2020Q3	us-gaap	Gross Profit GrossProfit	0	USD
	us-gaap	Gross Profit GrossProfit	0	USD
	us-gaap	Gross Profit GrossProfit	21000	USD
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	78896000	USD
CY2020Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	51496000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	201785000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	118098000	USD
CY2021Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	192929000	USD
CY2020Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	65782000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	329028000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	117821000	USD
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	271825000	USD
CY2020Q3	us-gaap	Operating Expenses OperatingExpenses	117278000	USD
	us-gaap	Operating Expenses OperatingExpenses	530813000	USD
	us-gaap	Operating Expenses OperatingExpenses	235919000	USD
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-271825000	USD
CY2020Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-117278000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-530813000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-235898000	USD
CY2021Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-118000	USD
CY2020Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	171000	USD
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-219000	USD
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	255000	USD
CY2021Q3	nkla	Gain Loss On Financial Instruments Subject To Mandatory Redemption GainLossOnFinancialInstrumentsSubjectToMandatoryRedemption	0	USD
CY2020Q3	nkla	Gain Loss On Financial Instruments Subject To Mandatory Redemption GainLossOnFinancialInstrumentsSubjectToMandatoryRedemption	0	USD
	nkla	Gain Loss On Financial Instruments Subject To Mandatory Redemption GainLossOnFinancialInstrumentsSubjectToMandatoryRedemption	0	USD
	nkla	Gain Loss On Financial Instruments Subject To Mandatory Redemption GainLossOnFinancialInstrumentsSubjectToMandatoryRedemption	-1324000	USD
CY2021Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-4467000	USD
CY2020Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-37745000	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-2907000	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-8588000	USD
CY2021Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1057000	USD
CY2020Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-340000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	174000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-249000	USD
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-266419000	USD
CY2020Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-79702000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-527951000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-228628000	USD
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1000	USD
CY2020Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4000	USD
CY2021Q3	nkla	Income Loss From Continuing Operations Before Equity Method Investments Noncontrolling Interest Net Of Tax IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterestNetOfTax	-266420000	USD
CY2020Q3	nkla	Income Loss From Continuing Operations Before Equity Method Investments Noncontrolling Interest Net Of Tax IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterestNetOfTax	-79704000	USD
	nkla	Income Loss From Continuing Operations Before Equity Method Investments Noncontrolling Interest Net Of Tax IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterestNetOfTax	-527955000	USD
	nkla	Income Loss From Continuing Operations Before Equity Method Investments Noncontrolling Interest Net Of Tax IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterestNetOfTax	-228632000	USD
CY2021Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1147000	USD
CY2020Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-3067000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	USD
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-267567000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-79704000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-531022000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-228632000	USD
CY2021Q3	us-gaap	Preferred Stock Redemption Premium PreferredStockRedemptionPremium	0	USD
CY2020Q3	us-gaap	Preferred Stock Redemption Premium PreferredStockRedemptionPremium	0	USD
	us-gaap	Preferred Stock Redemption Premium PreferredStockRedemptionPremium	0	USD
	us-gaap	Preferred Stock Redemption Premium PreferredStockRedemptionPremium	13407000	USD
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-267567000	USD
CY2020Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-79704000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-531022000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-242039000	USD
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.67
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.21
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.34
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.76
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.68
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.31
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.35
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.79
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	400219585	shares
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	377660477	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	395691795	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	318315891	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	400230669	shares
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	378286678	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	395860876	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	318976447	shares
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-267567000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-79704000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-531022000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-228632000	USD
CY2021Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-123000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	0	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-358000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	0	USD
CY2021Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-267690000	USD
CY2020Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-79704000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-531380000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-228632000	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	844777000	USD
CY2021Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	355000	USD
CY2021Q3	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	2939000	USD
CY2021Q3	nkla	Adjustments To Additional Paid In Capital Elimination Of Put Right AdjustmentsToAdditionalPaidInCapitalEliminationOfPutRight	5532000	USD
CY2021Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	72866000	USD
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	49047000	USD
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-267567000	USD
CY2021Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-123000	USD
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	707826000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	980141000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3981000	USD
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	5564000	USD
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	19139000	USD
	nkla	Adjustments To Additional Paid In Capital Elimination Of Put Right AdjustmentsToAdditionalPaidInCapitalEliminationOfPutRight	5532000	USD
CY2020Q2	nkla	Conversion Of Stock Shares Issued Conversion Rate ConversionOfStockSharesIssuedConversionRate	1.901
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	72866000	USD
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	151983000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-531022000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-358000	USD
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	707826000	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	829947000	USD
CY2020Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	320000	USD
CY2020Q3	nkla	Adjustments To Additional Paid In Capital Warrants Exercised AdjustmentsToAdditionalPaidInCapitalWarrantsExercised	263064000	USD
CY2020Q3	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	52196000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-79704000	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	1065823000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	195508000	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	8403000	USD
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	56250000	USD
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	91999000	USD
	nkla	Shares Issued During Period Value Recapitalization SharesIssuedDuringPeriodValueRecapitalization	594522000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2204000	USD
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	91736000	USD
	nkla	Adjustments To Additional Paid In Capital Warrants Exercised AdjustmentsToAdditionalPaidInCapitalWarrantsExercised	263064000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-228632000	USD
CY2020Q3	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2020Q3	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	1065823000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-531022000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-228632000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5959000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4424000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	151983000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	91736000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	2000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	4000	USD
	nkla	Non Cash In Kind Services NonCashInKindServices	40230000	USD
	nkla	Non Cash In Kind Services NonCashInKindServices	28642000	USD
	nkla	Gain Loss On Financial Instruments Subject To Mandatory Redemption GainLossOnFinancialInstrumentsSubjectToMandatoryRedemption	0	USD
	nkla	Gain Loss On Financial Instruments Subject To Mandatory Redemption GainLossOnFinancialInstrumentsSubjectToMandatoryRedemption	-1324000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-3067000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-2907000	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-8588000	USD
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	319000	USD
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	0	USD
	nkla	Issuance Of Stock For Commitment Shares IssuanceOfStockForCommitmentShares	5564000	USD
	nkla	Issuance Of Stock For Commitment Shares IssuanceOfStockForCommitmentShares	0	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-1008000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3644000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	0	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	7090000	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-271000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	147160000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	19398000	USD
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-4705000	USD
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	6823000	USD
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-655000	USD
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	0	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-195369000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-84598000	USD
	us-gaap	Payments To Acquire Other Property Plant And Equipment PaymentsToAcquireOtherPropertyPlantAndEquipment	113680000	USD
	us-gaap	Payments To Acquire Other Property Plant And Equipment PaymentsToAcquireOtherPropertyPlantAndEquipment	15180000	USD
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	25000000	USD
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	15000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	200000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-138480000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-15195000	USD
	nkla	Proceeds From Recapitalization Transaction ProceedsFromRecapitalizationTransaction	0	USD
	nkla	Proceeds From Recapitalization Transaction ProceedsFromRecapitalizationTransaction	616726000	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	4194000	USD
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	759000	USD
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	789000	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	2204000	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	263064000	USD
	nkla	Proceeds From Finance Lease ProceedsFromFinanceLease	0	USD
	nkla	Proceeds From Finance Lease ProceedsFromFinanceLease	889000	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	4134000	USD
	us-gaap	Repayments Of Debt RepaymentsOfDebt	4100000	USD
	us-gaap	Repayments Of Debt RepaymentsOfDebt	4134000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	644000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	71557000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	932443000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-262292000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	832650000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	849278000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	89832000	USD
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	586986000	USD
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	922482000	USD
	us-gaap	Interest Paid Net InterestPaidNet	573000	USD
	us-gaap	Interest Paid Net InterestPaidNet	683000	USD
	nkla	Interest Received InterestReceived	456000	USD
	nkla	Interest Received InterestReceived	887000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	21001000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	2136000	USD
	nkla	Accrued Deferred Issuance Costs AccruedDeferredIssuanceCosts	439000	USD
	nkla	Accrued Deferred Issuance Costs AccruedDeferredIssuanceCosts	0	USD
	nkla	Noncash Prepaid In Kind Services NoncashPrepaidInKindServices	0	USD
	nkla	Noncash Prepaid In Kind Services NoncashPrepaidInKindServices	63358000	USD
	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	0	USD
	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	285000	USD
	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	285000	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	11125000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	0	USD
	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	21919000	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	USD
	us-gaap	Stock Issued1 StockIssued1	5564000	USD
	us-gaap	Stock Issued1 StockIssued1	0	USD
	us-gaap	Other Significant Noncash Transaction Value Of Consideration Given1 OtherSignificantNoncashTransactionValueOfConsiderationGiven1	32376000	USD
	us-gaap	Other Significant Noncash Transaction Value Of Consideration Given1 OtherSignificantNoncashTransactionValueOfConsiderationGiven1	0	USD
	nkla	Settlement Of Financial Instruments Subject To Mandatory Redemption SettlementOfFinancialInstrumentsSubjectToMandatoryRedemption	0	USD
	nkla	Settlement Of Financial Instruments Subject To Mandatory Redemption SettlementOfFinancialInstrumentsSubjectToMandatoryRedemption	1324000	USD
	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	47181000	USD
	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	0	USD
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	587000000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	840900000	USD
CY2021Q3	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	0	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	8400000	USD
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	586986000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	840913000	USD
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	907530000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	85688000	USD
CY2021Q3	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	0	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	4365000	USD
CY2020Q3	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	10952000	USD
CY2019Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	0	USD
CY2021Q3	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	0	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	4000000	USD
CY2020Q3	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	4000000	USD
CY2019Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	4144000	USD
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	586986000	USD
CY2020Q2	nkla	Common Stock And Preferred Stock Shares Authorized CommonStockAndPreferredStockSharesAuthorized	750000000	shares
CY2020Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000	shares
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	849278000	USD
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	922482000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	89832000	USD
CY2021Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	4428000	USD
CY2021Q3	us-gaap	Derivative Liabilities DerivativeLiabilities	7386000	USD
CY2020Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	7335000	USD
CY2021Q3	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P3Y8M1D
CY2020Q4	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P4Y5M1D
CY2020Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	150000000	shares
CY2020Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	525000000	USD
	us-gaap	Repayments Of Assumed Debt RepaymentsOfAssumedDebt	422000	USD
	nkla	Proceeds From Recapitalization Transaction ProceedsFromRecapitalizationTransaction	616726000	USD
	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	285000	USD
	nkla	Cash Recapitalization Net CashRecapitalizationNet	594522000	USD
CY2020Q2	nkla	Shares Issued During Period Shares Recapitalization SharesIssuedDuringPeriodSharesRecapitalization	72272942	shares
CY2020Q2	nkla	Common Stock Shares Outstanding Prior To Conversion CommonStockSharesOutstandingPriorToConversion	288631536	shares
CY2020Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	360904478	shares
CY2020Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	151831441	shares
CY2020Q2	nkla	Conversion Of Stock Shares Issued Conversion Rate ConversionOfStockSharesIssuedConversionRate	1.901
CY2021Q3	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	3644000	USD
	us-gaap	Depreciation Depreciation	5900000	USD
CY2021Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	0	USD
CY2021Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	0	USD
CY2021Q3	us-gaap	Inventory Net InventoryNet	3644000	USD
CY2021Q3	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	209370000	USD
CY2020Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	79816000	USD
CY2021Q3	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	8715000	USD
CY2020Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	8415000	USD
CY2021Q3	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	200655000	USD
CY2020Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	71401000	USD
CY2021Q3	us-gaap	Finance Lease Liability FinanceLeaseLiability	25100000	USD
CY2021Q3	nkla	Finance Lease Liability Remeasurement Adjustment FinanceLeaseLiabilityRemeasurementAdjustment	10500000	USD
CY2021Q3	us-gaap	Depreciation Depreciation	2200000	USD
CY2020Q3	us-gaap	Depreciation Depreciation	1500000	USD
	us-gaap	Depreciation Depreciation	4400000	USD
CY2021Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3563000	USD
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1105000	USD
CY2021Q3	nkla	Accrued Stock Issuance Costs Current AccruedStockIssuanceCostsCurrent	439000	USD
CY2020Q4	nkla	Accrued Stock Issuance Costs Current AccruedStockIssuanceCostsCurrent	285000	USD
CY2021Q3	nkla	Accrued Outsourced Engineering Services Current AccruedOutsourcedEngineeringServicesCurrent	6438000	USD
CY2020Q4	nkla	Accrued Outsourced Engineering Services Current AccruedOutsourcedEngineeringServicesCurrent	2514000	USD
CY2021Q3	nkla	Accrued Purchases Of Property And Equipment Current AccruedPurchasesOfPropertyAndEquipmentCurrent	3878000	USD
CY2020Q4	nkla	Accrued Purchases Of Property And Equipment Current AccruedPurchasesOfPropertyAndEquipmentCurrent	2533000	USD
CY2021Q3	nkla	Accrued Legal Liabilities Current AccruedLegalLiabilitiesCurrent	5373000	USD
CY2020Q4	nkla	Accrued Legal Liabilities Current AccruedLegalLiabilitiesCurrent	8845000	USD
CY2021Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	7386000	USD
CY2020Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	0	USD
CY2021Q3	nkla	Accrued Purchases Of Intangible Assets Current AccruedPurchasesOfIntangibleAssetsCurrent	11577000	USD
CY2020Q4	nkla	Accrued Purchases Of Intangible Assets Current AccruedPurchasesOfIntangibleAssetsCurrent	0	USD
CY2021Q3	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	125000000	USD
CY2020Q4	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	0	USD
CY2021Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	7230000	USD
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2457000	USD
CY2021Q3	nkla	Accrued Liabilities And Other Liabilities Current AccruedLiabilitiesAndOtherLiabilitiesCurrent	170884000	USD
CY2020Q4	nkla	Accrued Liabilities And Other Liabilities Current AccruedLiabilitiesAndOtherLiabilitiesCurrent	17739000	USD
CY2021Q3	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	97181000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	0	USD
CY2021Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	97181000	USD
CY2020Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	50150000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	100000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	50050000	USD
CY2019Q1	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.0300
CY2021Q3	nkla	Common Stock And Preferred Stock Shares Authorized CommonStockAndPreferredStockSharesAuthorized	750000000	shares
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000	shares
CY2021Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	150000000	shares
CY2021Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-4500000	USD
CY2020Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-37700000	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-2900000	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-8600000	USD
CY2021Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	4400000	USD
CY2020Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	7300000	USD
CY2021Q2	nkla	Sale Of Stock Purchase Period SaleOfStockPurchasePeriod	P36M
CY2021Q2	nkla	Issuance Of Stock For Commitment Shares IssuanceOfStockForCommitmentShares	2600000	USD
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	42802865	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	32529224	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.28
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y9M25D
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2021Q3	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	3182359	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.25
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	47023	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	2.71
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	29299842	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.28
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y1M13D
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	28683443	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1.25
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P7Y1M6D
CY2021Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	49047000	USD
CY2020Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	52196000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	151983000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	91736000	USD
CY2021Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	359646000	USD
CY2020Q3	nkla	Number Of Class Action Lawsuits NumberOfClassActionLawsuits	6	lawsuit
CY2020Q3	nkla	Number Of Derivative Actions NumberOfDerivativeActions	2	derivativeAction
CY2020Q4	nkla	Period Of Derivative Action PeriodOfDerivativeAction	P30D
CY2021Q1	nkla	Period Of Derivative Action PeriodOfDerivativeAction	P30D
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-267567000	USD
CY2020Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-79704000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-531022000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-242039000	USD
CY2021Q3	us-gaap	Dilutive Securities DilutiveSecurities	-4467000	USD
CY2020Q3	us-gaap	Dilutive Securities DilutiveSecurities	-37745000	USD
	us-gaap	Dilutive Securities DilutiveSecurities	-2907000	USD
	us-gaap	Dilutive Securities DilutiveSecurities	-8588000	USD
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-272034000	USD
CY2020Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-117449000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-533929000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-250627000	USD
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	400219585	shares
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	377660477	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	395691795	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	318315891	shares
CY2021Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	11084	shares
CY2020Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	626201	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	169081	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	660556	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	400230669	shares
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	378286678	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	395860876	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	318976447	shares
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.67
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.21
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.34
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.76
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.68
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.31
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.35
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.79
CY2021Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	53619079	shares
CY2020Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	54225040	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	53619079	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	54225040	shares

Files In Submission

Name	View Source	Status
0001731289-21-000124-index-headers.html	Edgar Link	pending
0001731289-21-000124-index.html	Edgar Link	pending
0001731289-21-000124.txt	Edgar Link	pending
0001731289-21-000124-xbrl.zip	Edgar Link	pending
amendmentno1tomembershipin.htm	Edgar Link	pending
exhibit311q321.htm	Edgar Link	pending
exhibit312q321.htm	Edgar Link	pending
exhibit321q321.htm	Edgar Link	pending
exhibit322q321.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
nikola-fcpmdesignandmanufa.htm	Edgar Link	pending
nikola-fuelcellsupplyframe.htm	Edgar Link	pending
nkla-20210930.htm	Edgar Link	pending
nkla-20210930.xsd	Edgar Link	pending
nkla-20210930_cal.xml	Edgar Link	unprocessable
nkla-20210930_def.xml	Edgar Link	unprocessable
nkla-20210930_htm.xml	Edgar Link	completed
nkla-20210930_lab.xml	Edgar Link	unprocessable
nkla-20210930_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NKLA
Nikola Corp Stock $nkla

2021 Q4 Form 10-Q Financial Statement

#000173128921000124 Filed on November 04, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NKLA Nikola Corp Stock $nkla

2021 Q4 Form 10-Q Financial Statement

#000173128921000124 Filed on November 04, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NKLA
Nikola Corp Stock $nkla